首页> 外文期刊>International Journal of Molecular Sciences >Battle Against Cancer: An Everlasting Saga of p53
【24h】

Battle Against Cancer: An Everlasting Saga of p53

机译:对抗癌症:p53的永恒传奇

获取原文
           

摘要

Cancer is one of the most life-threatening diseases characterized by uncontrolled growth and spread of malignant cells. The tumor suppressor p53 is the master regulator of tumor cell growth and proliferation. In response to various stress signals, p53 can be activated and transcriptionally induces a myriad of target genes, including both protein-encoding and non-coding genes, controlling cell cycle progression, DNA repair, senescence, apoptosis, autophagy and metabolism of tumor cells. However, around 50% of human cancers harbor mutant p53 and, in the majority of the remaining cancers, p53 is inactivated through multiple mechanisms. Herein, we review the recent progress in understanding the molecular basis of p53 signaling, particularly the newly identified ribosomal stress—p53 pathway, and the development of chemotherapeutics via activating wild-type p53 or restoring mutant p53 functions in cancer. A full understanding of p53 regulation will aid the development of effective cancer treatments.
机译:癌症是最致命的疾病之一,其特征是恶性细胞的生长和扩散不受控制。肿瘤抑制因子p53是肿瘤细胞生长和增殖的主要调节剂。响应各种应激信号,p53可以被激活并转录诱导多种靶基因,包括蛋白质编码和非编码基因,从而控制细胞周期进程,DNA修复,衰老,凋亡,自噬和肿瘤细胞的代谢。但是,大约50%的人类癌症带有p53突变体,而在其余大多数癌症中,p53是通过多种机制失活的。本文中,我们回顾了在理解p53信号的分子基础,尤其是新近鉴定的核糖体应激-p53途径,以及通过激活野生型p53或恢复癌症中的突变p53功能的化学疗法方面的进展。对p53调控的全面了解将有助于开发有效的癌症治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号